Skip to main content
. 2020 Aug 6;11(9):2660–2671. doi: 10.1111/1759-7714.13603

Figure 2.

Figure 2

(a) The expressions of CirCHIPK3 in normal and breast cancer cells. (b) MDA‐MB‐231 cell proliferation was detected by MTT assay following si‐CirCHIPK3 and OE‐ CirCHIPK3 (*P < 0.05,**P < 0.01) (Inline graphic) si‐CircHIPK3, (Inline graphic) si‐CircNC, (Inline graphic) OE‐CircNC, (Inline graphic) OE‐CircHIPK3. (c) MCF‐7 cell proliferation was detected by MTT assay following si‐CirCHIPK3 and OE‐CirCHIPK3 (*P < 0.05,**P < 0.01) (Inline graphic) si‐CircHIPK3, (Inline graphic) si‐CircNC, (Inline graphic) OE‐CircNC, (Inline graphic) OE‐CircHIPK3. (d and f) Wound healing assay for migration rate after 0, 24 and 48 hours using MDA‐MB‐231 cells following si‐CirCHIPK3 and OE‐CirCHIPK3 (*P < 0.05,**P < 0.01) (Inline graphic) si‐CircHIPK3, (Inline graphic) si‐CircNC, (Inline graphic) OE‐CircNC, (Inline graphic) OE‐CircHIPK3. (e and g) Transwell invasion assay for tumor cell invasion after 0, 24 and 48 hours using MDA‐MB‐231 cells following si‐CirCHIPK3 and OE‐ CirCHIPK3 (*P < 0.05,**P < 0.01).